🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsOral GLP-1 AgonistsPLEASE just give me a pill already I hate needles so much

PLEASE just give me a pill already I hate needles so much

tammy_FL Mon, May 11, 2026 at 5:46 PM 15 replies 575 viewsPage 1 of 3
tammy_FL
Member
234
890
Nov 2024
Tampa, FL
May 11, 2026 at 5:46 PM#1

I switched from injectable to oral semaglutide for travel reasons and the fasting window is proving harder to hold than the injection ever was.

The practical numbers: about 1% oral bioavailability, 30 minutes fasted before food, no more than 120ml of plain water, and coffee counts as food for this purpose.

What would genuinely help is knowing whether the fasting requirement is as strict in practice as the label implies, and what people actually see when they get it wrong.

I would rather have one careful answer than five confident ones.

26 21Dr.LipidDallas, alex_tucson, kevin_tulsa and 23 others
Reply Quote Save Share Report
LibrarianMeg
Senior Member
1,678
7,890
Mar 2024
Baltimore, MD
May 11, 2026 at 5:56 PM#2

Taking the question as asked, rather than the general version of it. Orforglipron is the more interesting oral story because it is not a peptide at all. Being a small molecule it does not need SNAC, does not need the fasting window, and has oral bioavailability in the tens of percent rather than about one.

25 20PharmD_Rodriguez, julia.endo, JessicaM_2024 and 22 others
Reply Quote Save Share Report
TinaHashiRN
Member
345
1,567
Sep 2024
Raleigh, NC
May 11, 2026 at 6:06 PM#3
LibrarianMeg said:
Orforglipron is the more interesting oral story because it is not a peptide at all.

No disagreement with LibrarianMeg. One condition attached. The absorption variability is real, but it partly averages out over weeks — the steady-state trough is less erratic than any single day would suggest. Where it bites is in the first fortnight, when people conclude the tablet does nothing.

Last edited: May 12, 2026 at 12:06 AM
24 19Dr.Martinez, mike_mod, SarahChen_PharmD and 21 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
AussieAnna
Member
678
2,890
Jun 2024
Sydney, AU
May 11, 2026 at 6:16 PM#4
tammy_FL said:
I switched from injectable to oral semaglutide for travel reasons and the fasting window is proving harder to hold than the injection ever was.

Can confirm the pattern tammy_FL describes. The OASIS programme put 50mg oral in the same territory as 2.4mg injectable — around 15% mean weight loss — but it needed a dose 20 times larger to get there because almost none of the tablet is absorbed. The dose numbers are not comparable across routes and quoting them side by side confuses people.

Last edited: May 11, 2026 at 7:16 PM
23 18bri_stats, pete_manc_UK, anna.melb_AU and 20 others
Reply Quote Save Share Report
Dr.ObesityMed
VIP Member
3,456
19,234
Nov 2023
Denver, CO
Online
May 11, 2026 at 7:09 PM#5

Clinical perspective, offered as context rather than as advice. If two explanations both fit, the useful question is which one predicts something the other does not. That is answerable; arguing about which sounds more plausible is not.

22 17A1cHero_PHX, Dr.RenalNash, LipidDoc_ATL and 19 others
Reply Quote Save Share Report

Similar Threads

Orforglipron Phase 3 ATTAIN-1 topline — oral non-peptide GLP-116 replies
Oral semaglutide 50mg (Rybelsus HD) — OASIS program results12 replies
Danuglipron BID dosing — Pfizer oral GLP-1 update7 replies
Oral vs injectable GLP-1: bioavailability and efficacy comparison5 replies
Orforglipron food interaction profile — no fasting requirement15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register